NewsOneSource Specialty Pharma Allots 3,150 Equity Shares Under ESOP 2021, Paid-Up Capital RisesOneSource Specialty Pharma Allots 3,150 Equity Shares Under ESOP 2021, Paid-Up Capital Rises
OneSource Specialty Pharma Limited allotted 3,150 equity shares of INR 1/- each on May 13, 2026, under ONESOURCE ESOP 2021, following the exercise of vested options by eligible employees. The allotment raised the company's paid-up share capital from INR 114,642,651/- to INR 114,645,801/-, with total issued shares now at 11,46,45,801. The shares were issued at an exercise price of INR 278.00 per share, carrying a premium of INR 277.00 per share, and rank pari passu with existing equity shares. The disclosure was made under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015.
*this image is generated using AI for illustrative purposes only.
On May 13, 2026, OneSource Specialty Pharma Limited's Board of Directors approved the allotment of 3,150 equity shares of INR 1/- each under the OneSource Specialty Pharma Limited – Employee Stock Option Plan 2021 (ONESOURCE ESOP 2021). The allotment was made to eligible employees of the company upon exercise of vested options, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. The newly issued shares rank pari passu with the existing equity shares of the company in all respects.
Impact on Paid-Up Share Capital
The allotment has resulted in an increase in the company's paid-up share capital. The following table summarises the change in share capital consequent to this allotment:
| Metric: | Before Allotment | After Allotment |
|---|---|---|
| Paid-Up Share Capital: | INR 114,642,651/- | INR 114,645,801/- |
| Number of Equity Shares: | 114,642,651 | 114,645,801 |
| Face Value Per Share: | INR 1/- | INR 1/- |
ESOP Allotment Details
The allotment has been made under the ONESOURCE ESOP 2021 scheme. Key details of the issuance, as disclosed under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, are presented below:
| Parameter: | Details |
|---|---|
| Scheme Name: | OneSource Specialty Pharma Limited – Employee Stock Option Plan 2021 |
| Kind of Security: | Equity Shares |
| Par Value Per Share: | INR 1/- |
| Date of Issue: | May 13, 2026 |
| Number of Shares Issued: | 3,150 |
| Distinctive Numbers: | 125731972 to 125735121 |
| Exercise Price Per Share: | INR 278.00 |
| Premium Per Share: | INR 277.00 |
| Total Issued Shares After Issue: | 11,46,45,801 |
| Total Issued Share Capital After Issue: | INR 11,46,45,801/- |
| Lock-In Details: | NA |
| Pari Passu with Existing Shares: | Yes |
Regulatory Compliance
The company filed the statement referred to in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with the stock exchanges on March 12, 2025. OneSource Specialty Pharma's shares are listed on both BSE Limited and the National Stock Exchange of India Limited. The disclosure was signed by Trisha A, Company Secretary and Compliance Officer (Membership Number: A47635), on behalf of the company.
Historical Stock Returns for Onesource Specialty Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.68% | +4.38% | +17.79% | +5.44% | +10.37% | +6.43% |
How many additional ESOP tranches are expected to vest under the ONESOURCE ESOP 2021 scheme in the coming quarters, and what is the potential dilution impact on existing shareholders?
Given the exercise price of INR 278 per share, how does this compare to OneSource Specialty Pharma's current market price, and what does this signal about employee sentiment toward the company's future growth prospects?
Will OneSource Specialty Pharma introduce a new ESOP scheme beyond 2021 to attract and retain talent as the company scales, and what size of employee stock pool might be considered?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
